Neuron23 Competitors and Similar CompaniesClear all
Neuron23's competitors and similar companies include SpliceBio and Sarepta Therapeutics.
 SpliceBio SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies. |  Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. | ||
Founding Date | Founding Date 2018 | Founding Date 2012 | Founding Date 1980 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Barcelona, ES HQ | Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US |
Employees | Employees 427% decrease | Employees 452% decrease | Employees 1,31413% increase |
Valuation ($) | Valuation ($) 507.1 m | Valuation ($) N/A | Valuation ($) 12.4 b |
Funding | |||
Latest funding round | Latest funding round $ 80m (over 5 years ago) | Latest funding round $ 2m (over 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 113.5m | Total funding raised $ 2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
SpliceBio
HQ
Barcelona, ES
Employees
45↓ 2% decrease
SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies.
View companySarepta Therapeutics
HQ
Cambridge, US
Employees
1,314↑ 13% increase
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
View company